gender=male;phenotype=non-tumor;subject_id=fa37be85256c1efbac0501eb13ae1daf9f0fcaff4a7cbb3d2f4420f70f75d334;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=fbfc6db2b112a17deba998fee516899a4e6acf64b784dd7289cb18f7cfe5d1c3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=7bc2eb9cbd76f57405c4db1820c587932da2dc3bc5396e612eaa68aec71f434d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=493bf7322b8c18365466c43bf7a9e119bd4d7782147f9bc368bf4909539c43de;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=4f7206365f5e132362b7810efb9b1797ddd516db3155fec497ef0c20014f90d3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=fea8e6717ae789b7a0d25764f7f96d653d0d4aab39892c2c6323aafdda63b4ba;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=e84d029db3c2d35a013a99913998cdcffcde540aef12dfa4a0f91ca771f0bed0;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=c72589bc8e2b3e3e7373fbf0b5adb4c67dfb65afa28950d68bc08e94b4e5f6e6;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=65563f8e715e1117c73623defb3159d94318f41306526f79f5ba6134f72a925a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=674447974a213869433fdecef1d7825dcfbd972fa94ee78e89300dcd4e90fda9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=42a2b2ad86b3d0f66ecec5ce1d8b0cca6e334d365d6434d2bf1050e9b2f97990;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ffe2e6c271347f25927c6e8975685a1b04934a0406f589f3df1608de00a7719f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=7848bd725874b4f28f5c907834fab039f1c9489938a6d78b770e367be2973da9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=0f48df24681bff9daca43ea351a061173146b5a347774916fe4c683d65016d10;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=3f09772b941e0dc3721126176238df54197fca741e9c633c0860bc68791c6e7a;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=04616fe602821be83f79e051c94c28347907f72d4e9ed5d7f1f50d4cfcd71d01;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=abe0a2a743467f12a0a73ea6ef97fb1e22252f323b8400b41fa90d4526b58d12;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=98011f8fb58fa8eed6171691d09d2ac7c67eb943046e45f70c47352c3a559887;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=c7bfd214f91659c29c94ced600fe7a2ec9409351d81f69446f129280522b09dd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=7bc2eb9cbd76f57405c4db1820c587932da2dc3bc5396e612eaa68aec71f434d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=4f7206365f5e132362b7810efb9b1797ddd516db3155fec497ef0c20014f90d3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=e84d029db3c2d35a013a99913998cdcffcde540aef12dfa4a0f91ca771f0bed0;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=65563f8e715e1117c73623defb3159d94318f41306526f79f5ba6134f72a925a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=0f48df24681bff9daca43ea351a061173146b5a347774916fe4c683d65016d10;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=acf69aa660142cf43def706fbb84f6b9214ffaa15e9a8b5dc86e42d1b80b182d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=fd3c269acb7e9136adf6d5418d5330e83f6bc68f865eb5ee0b529956ca6e8747;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=815b14fc82802994d6234dbab1f4acf7fd67c3a1dc2c7b23418c82c61f08e91e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=712aa46874b09ab06deba81351c03488694017f501de44f067bac388b622da01;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=ec1086015889ae545b0cb5b98d60a7a02bafe2a5650f7e32990ace37c08e5f1c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6b5067457342d37b517770cbb38061c57a9b6264724dccedf068f6fb6668663b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2fb1c6063e7eac401741e82a2ac128bcb29d26f1f7f301a41db9878ab7813f6f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=51061bea37675a197e1e8e1cfeac9df7efd12166082308a3f471c61fb9005735;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=582a585182fcbf965e2f8fbab693d758f1838b685f002c0ad06aed112b99531d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=efab5fcee88a0b39b42a69c06217ee8eb2163fe6737a38d90c549c14705b4172;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=809f380be25b144a6197d915114cf007951bf3e5cf08729e1be5182611578bf6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=86c633a436916422e25c43063f1d8fde99dfbcb303747adcce0d3da8cc1c3183;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=b2f3a00c65761babe08a8a09c89691ee12894d2a0291d029cc4786fcf0dd6ed4;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=b36a54f3952a12ee5c34f2e8ab1b5ae41c4f5a1eb843081b71a2f89529cc607c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ebf7ea541c0d14c205dd1a7d16ed894a4ef2c0d5796122bf22a791b5114859da;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=5efa2bbba4ebf72d558238583771ee85eb026dd17fb4aaf11f2e50988ab8cb79;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=aacbb2aa070b806093aadacc0466a763cee154f567646cc2ba433b7f6869c248;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=3f033a2314ecd6d19bd09179af1fd688ee38da8a63ea2b0879ec99d86e7460d6;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=acf69aa660142cf43def706fbb84f6b9214ffaa15e9a8b5dc86e42d1b80b182d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=bd8b41d77f905bd068f01e8ac5dc0b7ef04d8ac2215d4154c0738348b8918278;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=fd3c269acb7e9136adf6d5418d5330e83f6bc68f865eb5ee0b529956ca6e8747;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=815b14fc82802994d6234dbab1f4acf7fd67c3a1dc2c7b23418c82c61f08e91e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=64565a24a525ce7b4e1a958d9ab3410a8ba5975337aa731ef00bab7625a20bc1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=712aa46874b09ab06deba81351c03488694017f501de44f067bac388b622da01;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=ec1086015889ae545b0cb5b98d60a7a02bafe2a5650f7e32990ace37c08e5f1c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6b5067457342d37b517770cbb38061c57a9b6264724dccedf068f6fb6668663b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=2fb1c6063e7eac401741e82a2ac128bcb29d26f1f7f301a41db9878ab7813f6f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=51061bea37675a197e1e8e1cfeac9df7efd12166082308a3f471c61fb9005735;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=582a585182fcbf965e2f8fbab693d758f1838b685f002c0ad06aed112b99531d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=76fc1cfd4a2e0c806b8ac8357d1c3ab9c603cda7e4346c39139d66ec59800699;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=89bab9e7f417efbc02ba5fbf3fe14630c12cbbfde41420e1e822417f0ca843ad;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=efab5fcee88a0b39b42a69c06217ee8eb2163fe6737a38d90c549c14705b4172;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=77977ef0417ba90d8554929ffcc512163c9a455ae47f2e6655324952075ab57e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=809f380be25b144a6197d915114cf007951bf3e5cf08729e1be5182611578bf6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=86c633a436916422e25c43063f1d8fde99dfbcb303747adcce0d3da8cc1c3183;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=b2f3a00c65761babe08a8a09c89691ee12894d2a0291d029cc4786fcf0dd6ed4;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=b36a54f3952a12ee5c34f2e8ab1b5ae41c4f5a1eb843081b71a2f89529cc607c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ebf7ea541c0d14c205dd1a7d16ed894a4ef2c0d5796122bf22a791b5114859da;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=5efa2bbba4ebf72d558238583771ee85eb026dd17fb4aaf11f2e50988ab8cb79;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=aacbb2aa070b806093aadacc0466a763cee154f567646cc2ba433b7f6869c248;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=3f033a2314ecd6d19bd09179af1fd688ee38da8a63ea2b0879ec99d86e7460d6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=bd8b41d77f905bd068f01e8ac5dc0b7ef04d8ac2215d4154c0738348b8918278;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=64565a24a525ce7b4e1a958d9ab3410a8ba5975337aa731ef00bab7625a20bc1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=76fc1cfd4a2e0c806b8ac8357d1c3ab9c603cda7e4346c39139d66ec59800699;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=89bab9e7f417efbc02ba5fbf3fe14630c12cbbfde41420e1e822417f0ca843ad;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=77977ef0417ba90d8554929ffcc512163c9a455ae47f2e6655324952075ab57e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=9bede39d73b7a98225f1f8ea85d513c1739d6c55a43f8b284a41a49ec0c9a9df;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=9bede39d73b7a98225f1f8ea85d513c1739d6c55a43f8b284a41a49ec0c9a9df;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=604eb83f15cd845a03ce9ea2cd3a953d92730ab01485915ecce85c1bdeb9f727;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=74854df07d95b6b1a2132579094fef3b8c13e8f81875e20143f4e19e49e5f446;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=adef0e9ec80a088f6b632bc006df596c95352367ba861b37ee8a875cc8f6102c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2e84eea0e07ed72ce78dbc3111fb143778370d58de40f30a66e36a37cc314191;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=625721c0e551208d32de7879e3cb04bb5cfe7573266d5aec45e58e306e186c70;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=5108af817a712e94d4f20406172cd020f05bdc131220b241bbc94e28c353c9b2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2a7d03d9baf47f8eb350e6993c8d7fb4e40c2b6a5aa3942b04b0fe98e697020b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=8b8bfea3af2e6628aabd6ed070192e8dccb16d9af2fae1b759ab63fb82f8e7a3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=823eddf546c8253ec7f422951166089c5ad26fec2e75a965efe3a5a6e43bcfe0;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6729b31463a1e912fe4187556be5de212ee7150ff1bbe2a9fabe990ef988484e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=70145187b71797a20da1daa158e859f297f5ff235c24e685ebf1c423e778b382;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=730015334ef3a709c18445d6ceb35becf86f4fc5635f6117c5ae1646ffea4aee;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=e3271ccee7d736f7a876d8582ce224239ba68d7558af1f46de04e7024b9511c3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=9c1aa33d8cca6743039c73afa57991b46d5aae3796e1a1d2f7ad8480deb57bf7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=26f2fa25ea0f6c5911c3bb6e831d1a0633ce4a1b295028b1d09ef01b66cec0e2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=33213ed7688e535922f25a5c920040d9bfda8801fd32ff3aaee12ae0ad627f48;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=b5ac3e4486fc321cc8b938f32cb5dadc810e4091b7e1bf0c8cf67fe3d1ad79d6;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=c92b6c3dc5d7ab373cca89e4261a451f1a5d86b4d5bc05d7136fabb995f4d353;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=e7af9a8f5176677e829f051de9d912d834c516322635042e4780a570683898ab;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=e4eff69a9c68de30334a87dc47345d6cb260f93719733c94e4a39daa23ac0cb1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=141c4e0d1424a013faa785ef2fb5fc1bd47e434f8fc7193b4ae34bb3432a35ed;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=94c34e2475b3d421a3a49b49b8ef2fe278718a688445204887a53b76c720895e;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=e8c62d34a531db3e667add461efc2088c2ab62a1a039b0873224d69c60b0797d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2368c29b6b700ca640ec887666c149533231d23ea32718f6f83469b5b7ad7aa4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=3d6f94f343bc3a4030461f304e31d6aea165b3bb39f965d71697c7db8c1cee47;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=604eb83f15cd845a03ce9ea2cd3a953d92730ab01485915ecce85c1bdeb9f727;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=74854df07d95b6b1a2132579094fef3b8c13e8f81875e20143f4e19e49e5f446;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=adef0e9ec80a088f6b632bc006df596c95352367ba861b37ee8a875cc8f6102c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=141c4e0d1424a013faa785ef2fb5fc1bd47e434f8fc7193b4ae34bb3432a35ed;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=94c34e2475b3d421a3a49b49b8ef2fe278718a688445204887a53b76c720895e;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=e8c62d34a531db3e667add461efc2088c2ab62a1a039b0873224d69c60b0797d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=2e84eea0e07ed72ce78dbc3111fb143778370d58de40f30a66e36a37cc314191;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=2368c29b6b700ca640ec887666c149533231d23ea32718f6f83469b5b7ad7aa4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=625721c0e551208d32de7879e3cb04bb5cfe7573266d5aec45e58e306e186c70;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=5108af817a712e94d4f20406172cd020f05bdc131220b241bbc94e28c353c9b2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=2a7d03d9baf47f8eb350e6993c8d7fb4e40c2b6a5aa3942b04b0fe98e697020b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=8b8bfea3af2e6628aabd6ed070192e8dccb16d9af2fae1b759ab63fb82f8e7a3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=823eddf546c8253ec7f422951166089c5ad26fec2e75a965efe3a5a6e43bcfe0;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=3d6f94f343bc3a4030461f304e31d6aea165b3bb39f965d71697c7db8c1cee47;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6729b31463a1e912fe4187556be5de212ee7150ff1bbe2a9fabe990ef988484e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=70145187b71797a20da1daa158e859f297f5ff235c24e685ebf1c423e778b382;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=730015334ef3a709c18445d6ceb35becf86f4fc5635f6117c5ae1646ffea4aee;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=e3271ccee7d736f7a876d8582ce224239ba68d7558af1f46de04e7024b9511c3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=9c1aa33d8cca6743039c73afa57991b46d5aae3796e1a1d2f7ad8480deb57bf7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=26f2fa25ea0f6c5911c3bb6e831d1a0633ce4a1b295028b1d09ef01b66cec0e2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=33213ed7688e535922f25a5c920040d9bfda8801fd32ff3aaee12ae0ad627f48;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=b5ac3e4486fc321cc8b938f32cb5dadc810e4091b7e1bf0c8cf67fe3d1ad79d6;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=c92b6c3dc5d7ab373cca89e4261a451f1a5d86b4d5bc05d7136fabb995f4d353;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=e7af9a8f5176677e829f051de9d912d834c516322635042e4780a570683898ab;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=e4eff69a9c68de30334a87dc47345d6cb260f93719733c94e4a39daa23ac0cb1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=5e8016e0d643f4bf71f9afa98548d2bbbb8a456b4a3b6b3175bf56e65e58908f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=bd0b25935bc8755ba84befd0ed0ccea133d82b094e0ffa3d4955e5b185c4e09f;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=d3012eb5c1795f63ef44bf0f03e6c91a8bc5bf93bdfa44288e02764c8dfcabb3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=41db2179d8691b0d49e9bc19245ac8af93d9c637a498ec7ab822269664452482;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=bb045204c5ffa7051c634c2e95e79c1cd747e7ef90f17f0028c79e8e43d17a9b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d0f07dbe50b17d281d72e7f09b962f4e75e676ff37d2497a1f6c721b17148d66;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=b9ea87e34b63b2829a4325cb9a3b6735aaf98ad39f4281a228b69dcdef430130;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=83e5f80b1c797b84fc0cb2cd64de1f93ba161fc7250d6638f1cfcdbfd8cbb1b6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=900fdae05c90e27aba521996cc05d0a83e32dec27c271a8f14e59fa84439ed34;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=b8b7637a8d22837847d02df6a4587bd93fcd2c9ed21ef04893336f3c7dd6ddba;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=2747cb2bda1947f81a644e04eff504ecc3bdbd1723259420fbabbb33c4d2c8c0;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=7ae50f527740acb2518d25e9953e1222479f6f57e53db6be4a67ba8cc2b02253;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=887c41c3bf89e0fe6d721f4407b024294f01af4937a412310681db9e9bb57e8c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=1653fc3624abafefb2732db164b723d47ea80920a4c2252398fe6ddd300ea997;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=826cb806c36242e06bda2a676b65446bc82ef365e10148aa36baec0b1afa872c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=2613d0db5e6407392aa2691ce6db2a4cd350b8258a38f9f6b83844d3b8272685;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=fbcc66da7a4073672ef3f6cc4217349773552ed719dd04f411cc2f1e55587453;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=4a1132bd3e8862b6dd112bd68d86287a243e252cc36df16ea0e4e18a0895bb5b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=1791449d2f01848f0d916bf0fe0ea5bbd445cac09cb4cfbb612f884153fc0297;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=a7376de8be895a08d2abb22b1e3ee2483fb47abc534d7c6a066b06b2f0d4459a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=bc79d401dc11ae3b9fb974a8e63e8bf333b96c1440945786d137f03674496f08;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=3b5faf7fabba6b596f14ce281d06ce54af4d06027722cfd3114b8f0dd0ab5ae5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a548137dbe60bc2b84a8a704085d87362687f3e1aec35c978535a00e3fbffa1c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=5b45e0020f3ea36f4d034583a794622a871f1d67e133f83e8e9eb716a69c5ebc;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=e4b80679fbce7ca2acb63fd127363572dc0ca706328a1932fdee2358a9080110;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a575fa3a084b236bdcc6c02c119e643d4bdd9cb84bcac4716fca07bc2b74fcf1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a291ec924b460d7dacd1deae82a5e9247c3770de28cd2f202014f24edd27fdbc;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=e93d48436c2be6a3704bb914c29940a4198d5c8d9f25d25de3cbf48db41c8c1c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6ba738d1b7f1289ce2bf360743238837586ae068c0b87a6bda8f7731589f8238;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=da39706c902081bc4de43f099bf43e63bd8e796caf962e6614b138ce648015ac;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=75ce1bd6dbaf2d4ca50f51e6c1f2a09f3275b080539a07ac7ed962ae72c5179f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f4661599926f32245eb1f3e52788501bd0897f45a6b27ca5cdede18edb14be28;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=b8b2821ff551cc8cbf1e4a991c8b194f55891abaf407569629bcb3acb131c19a;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=cd056b00c8eea9e5c9bcae0bdf268f74dcd3ff4ab85c71752c76792e7937234b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d9ae1705ce0b4462ff82a46be3d5304819ffddc3715bbb6afd6e6181b8519846;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=be968792772699a12e22c87670fa3f80e7c142271bdd98b62f4fb62f8fd4595c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=c663059a37d1a1a67f9db09184aba83ae618af0e1717aaa1650eb81abaa83e10;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=5653075dfbef8dbf0fd2c89d49e162c3decfdf3b62db87ee57a7124937af2792;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=490ae7348c12a59b53192e341610b5c588783c80cbd969631ecf953ad0baf508;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=1395dc4ab7c754e0a84c8daa3996f16e5caf11169f8a9be6c800f6da00474321;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=c9db481edc32ce76746d2f099953d6010d3bd2d53c4ede5b89c5339ce551798c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f12cb40ba608e9ba3fd0d02ba87d2b42dc97e4a7c12debe83992b750aa93f2f2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=69f1b2078352cbdee29724b705114ad434578dbfadf5a8df2f82fdf3cde3f72b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=94649c5b2157e86623cef4ed305f17ab35a8026fde844bf59ba8763b5949c417;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=b1e3464f5718a6c674ee1a8da4a92ab7cc4f892e1b2e7a25cc7401f5c734124e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d79836f11b8c4e35b1d6ea1b73432c12faf524365b705494a0b69a6a96e81dca;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=37b56a8f3ae8e0f59bb17651a17a967c62f68204140b18b7d013c9eb709c69d2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ea9ee2acb5fbb50f049bddc8297fe4cb8652b8990328281283bddb5b6cdb920c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=0de0307feaaebcd92622acc19aae9d7ee9ba2f58ebfbfa0f8523e7c4f1b6b3ed;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=8812182da457dd94138bb1bd66a4c1daeccb446a4c79d31b05d0c0bfb1ff3507;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=913ce613b66ab4f7fda444db13933c39c689bef153aaa1cbe05db00e4aa7a1a4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=b8bfd29057a30c787f3ce32ad6fd64aeb349043a52c25d917cb28644bc0a48a0;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=57b7a98ac74112257612b3cadd241ef30d2cf823cac485e03f450365b7c6c789;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=dc28fc658e49e8706e5bc935d936179bb301b40fa1c23c6b4a79e12a72ead1e3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=900fdae05c90e27aba521996cc05d0a83e32dec27c271a8f14e59fa84439ed34;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=b8b7637a8d22837847d02df6a4587bd93fcd2c9ed21ef04893336f3c7dd6ddba;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2747cb2bda1947f81a644e04eff504ecc3bdbd1723259420fbabbb33c4d2c8c0;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=7ae50f527740acb2518d25e9953e1222479f6f57e53db6be4a67ba8cc2b02253;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=887c41c3bf89e0fe6d721f4407b024294f01af4937a412310681db9e9bb57e8c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=1653fc3624abafefb2732db164b723d47ea80920a4c2252398fe6ddd300ea997;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=826cb806c36242e06bda2a676b65446bc82ef365e10148aa36baec0b1afa872c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2613d0db5e6407392aa2691ce6db2a4cd350b8258a38f9f6b83844d3b8272685;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=fbcc66da7a4073672ef3f6cc4217349773552ed719dd04f411cc2f1e55587453;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=4a1132bd3e8862b6dd112bd68d86287a243e252cc36df16ea0e4e18a0895bb5b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=078773cc36a9ab58ece5c92e50368462dea52ded70f1b0da8c66e65066a3ce53;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=1791449d2f01848f0d916bf0fe0ea5bbd445cac09cb4cfbb612f884153fc0297;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=a7376de8be895a08d2abb22b1e3ee2483fb47abc534d7c6a066b06b2f0d4459a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=bc79d401dc11ae3b9fb974a8e63e8bf333b96c1440945786d137f03674496f08;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=3b5faf7fabba6b596f14ce281d06ce54af4d06027722cfd3114b8f0dd0ab5ae5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a548137dbe60bc2b84a8a704085d87362687f3e1aec35c978535a00e3fbffa1c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=5b45e0020f3ea36f4d034583a794622a871f1d67e133f83e8e9eb716a69c5ebc;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d297f88c680bb3e403b8cbc5f0fa85bbff0b31f1a2c12ded70e1a95e58580ed9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a307c661f084fb97799f6a166600734b68b727006909a0b10ce525f1b6415aa8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=5da22e00966d4943aec9b7a576a2b19142226ea471f15fc5af051c53878b972c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=2089c7c80de49c60c49a01deba8c80587307319d94d23b8464cbe53d2f1d4947;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=2c62164585fe00eb93465364e38cf2b51b4c8f2c60d39c1d02847f332d4a408a;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=f0a60d6e4aad4d410a44b5a3ec34937f208723b909b2ac8d47beaf01bbc47b15;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=60371515e3cfb0e8639b418a30914bd018549608079e0b534a237d1c38c5da92;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=997182d49057aa54375e2da5d222b23aa7b30b020f1e961aca988765aa0b1e08;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=ca7711a3704bf6c3c53c8da9151d70fb1b412e52dab8a03e3380611d9669e750;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=953dec19dc05015c97eb8cf35a0a4fabf53021d2fb65e7f4e770886db560e5f2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=4b835a2c95eb284c4c3d48acdb251e067134f9789ebe63e622dae04ad3c286ee;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=32f6dd0cf166e5d3a0a43d41f24ecbe88f1dae02f2aa8f52611b4211877cfecf;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=040c323ac201378d9e3acb214b1420e07867e7f6ed2f255f9226ea0c7e2e6f62;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f0b27a5c1dec65e39603bbdf0f8b3943b12d34a9bc9e33ed76b142e9242606c5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=47c4c85dbaca7b6e9e803f300c3d96a065ef3935c57390e6a6f4f29e6e8e6e3f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ababdefc84d79651cc5cbee04223ebff2d3479f79542ab018ed7dd62c21fbb06;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=071d0791a2371be080640b76eab4cf34bedc1198d4e58a37992e39e66ad2ed34;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=c60ea332ac60a35404032dad8cda635f834429b2040098e2cb247d2f54b6b4e9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=9ea99e16eaaf486784cb0cd7e1c846a4dcc7bbaecfccc9a04d7853093f2cf775;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=db31fa7c88d25e611a335be7e5374be4c905a9079063b04fe81905e55a7d1020;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a7e6decafefc73c92fe85040820d83bd4b1c326689b6e9452a160d25bc980a98;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=5fe63c5afb784fb862923cdaa8dbd1bd6765043759eb0ae4272e035b220171b2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=9aa3acd19da6ad36a8206d2dc11b4e8f54a1ba392aa4ae6ef853a174f016ab8d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=310c15daca2145583e440e9a6ab0a6052fa4d08b785d6455e961ddce5f4196fe;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=0690f491108b0e56fd9901e02e68a918868ec8c5ab8772bcd8ae6ff931169d84;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=74ffea6045f9ff44c0e3b46fe32fa30de6e616cd174fa30d5349a362f51424dd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ddbe3673feb6caaa40694506650420d1feeb0bd3de13ee81576efb6322e79ee1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=66d29a68f9536abe282a5321902b40627b171515b4862c0f41556d682f23be75;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=e308def3a33079a84267fe54fe2e611bcf37616a0b05c1a6586db411f5fa1086;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=ba008d8420c4c99b5649df06ad0963679f745af843694ab2177999e77007f274;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d2f9a56f010f5bc0e3d65890a416e91d6ce69b2bcb1c0f76de9345dd835fe6bb;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=5a14b5248d76d98bda5dbcd1450b97ed6d6924045908299241f47080e057b505;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=29b372caca7ac0df55f16fe9ce18e52022cee07eeed4ed6692bb5210aa7aa417;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=be676cca94bc8602cb0eef47fafa62ae3665d31d7eae696604c0b2d1c11a4cbd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=66af59b0d91faab37629ca055f6286e4f6313b7e4250a9902c03c58d022219ac;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=5508a19531d9031685aba3008e0d3340a4cab684b5c62b1b1926d429d35c60c3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a75a28c079f8d2907b6d787d42321aa9181af4a2ea11661ddeb2c64880fb1f21;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=c4577b94393c6a47c5033065ba9a879329432ceb9cb8b6ee590c9023e0c9efb5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=af2e66fc3118bd5100b0d503caedda230b2b515a097537f873cd0190a115d44f;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=0055e71c7c03d4ff4d57cd363f052914434bd306aff231125413c4703a30c84e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ec1b7dd053c6288890ebba70cf1089af8943d7c5876796aaaa527b7a4131794b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=b5217a2605627aca89ea9e9cf416cb25699e1a2a080d332592db3b272750fb9e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=88bbe83f6491f18fc9b694832f24793ff4e04cad590367aaee7db3a11644dc04;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d297f88c680bb3e403b8cbc5f0fa85bbff0b31f1a2c12ded70e1a95e58580ed9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a307c661f084fb97799f6a166600734b68b727006909a0b10ce525f1b6415aa8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=5da22e00966d4943aec9b7a576a2b19142226ea471f15fc5af051c53878b972c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2089c7c80de49c60c49a01deba8c80587307319d94d23b8464cbe53d2f1d4947;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2c62164585fe00eb93465364e38cf2b51b4c8f2c60d39c1d02847f332d4a408a;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=f0a60d6e4aad4d410a44b5a3ec34937f208723b909b2ac8d47beaf01bbc47b15;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=60371515e3cfb0e8639b418a30914bd018549608079e0b534a237d1c38c5da92;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=997182d49057aa54375e2da5d222b23aa7b30b020f1e961aca988765aa0b1e08;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=ca7711a3704bf6c3c53c8da9151d70fb1b412e52dab8a03e3380611d9669e750;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=953dec19dc05015c97eb8cf35a0a4fabf53021d2fb65e7f4e770886db560e5f2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=4b835a2c95eb284c4c3d48acdb251e067134f9789ebe63e622dae04ad3c286ee;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=32f6dd0cf166e5d3a0a43d41f24ecbe88f1dae02f2aa8f52611b4211877cfecf;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=040c323ac201378d9e3acb214b1420e07867e7f6ed2f255f9226ea0c7e2e6f62;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f0b27a5c1dec65e39603bbdf0f8b3943b12d34a9bc9e33ed76b142e9242606c5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=47c4c85dbaca7b6e9e803f300c3d96a065ef3935c57390e6a6f4f29e6e8e6e3f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ababdefc84d79651cc5cbee04223ebff2d3479f79542ab018ed7dd62c21fbb06;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=071d0791a2371be080640b76eab4cf34bedc1198d4e58a37992e39e66ad2ed34;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=c60ea332ac60a35404032dad8cda635f834429b2040098e2cb247d2f54b6b4e9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=9ea99e16eaaf486784cb0cd7e1c846a4dcc7bbaecfccc9a04d7853093f2cf775;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=db31fa7c88d25e611a335be7e5374be4c905a9079063b04fe81905e55a7d1020;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a7e6decafefc73c92fe85040820d83bd4b1c326689b6e9452a160d25bc980a98;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=5fe63c5afb784fb862923cdaa8dbd1bd6765043759eb0ae4272e035b220171b2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=9aa3acd19da6ad36a8206d2dc11b4e8f54a1ba392aa4ae6ef853a174f016ab8d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=310c15daca2145583e440e9a6ab0a6052fa4d08b785d6455e961ddce5f4196fe;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=0690f491108b0e56fd9901e02e68a918868ec8c5ab8772bcd8ae6ff931169d84;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=74ffea6045f9ff44c0e3b46fe32fa30de6e616cd174fa30d5349a362f51424dd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ddbe3673feb6caaa40694506650420d1feeb0bd3de13ee81576efb6322e79ee1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=66d29a68f9536abe282a5321902b40627b171515b4862c0f41556d682f23be75;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=e308def3a33079a84267fe54fe2e611bcf37616a0b05c1a6586db411f5fa1086;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=ba008d8420c4c99b5649df06ad0963679f745af843694ab2177999e77007f274;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d2f9a56f010f5bc0e3d65890a416e91d6ce69b2bcb1c0f76de9345dd835fe6bb;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=5a14b5248d76d98bda5dbcd1450b97ed6d6924045908299241f47080e057b505;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=29b372caca7ac0df55f16fe9ce18e52022cee07eeed4ed6692bb5210aa7aa417;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=be676cca94bc8602cb0eef47fafa62ae3665d31d7eae696604c0b2d1c11a4cbd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=66af59b0d91faab37629ca055f6286e4f6313b7e4250a9902c03c58d022219ac;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=5508a19531d9031685aba3008e0d3340a4cab684b5c62b1b1926d429d35c60c3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a75a28c079f8d2907b6d787d42321aa9181af4a2ea11661ddeb2c64880fb1f21;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=c4577b94393c6a47c5033065ba9a879329432ceb9cb8b6ee590c9023e0c9efb5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=af2e66fc3118bd5100b0d503caedda230b2b515a097537f873cd0190a115d44f;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=0055e71c7c03d4ff4d57cd363f052914434bd306aff231125413c4703a30c84e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ec1b7dd053c6288890ebba70cf1089af8943d7c5876796aaaa527b7a4131794b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=b5217a2605627aca89ea9e9cf416cb25699e1a2a080d332592db3b272750fb9e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=88bbe83f6491f18fc9b694832f24793ff4e04cad590367aaee7db3a11644dc04;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=5e8016e0d643f4bf71f9afa98548d2bbbb8a456b4a3b6b3175bf56e65e58908f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=bd0b25935bc8755ba84befd0ed0ccea133d82b094e0ffa3d4955e5b185c4e09f;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=d3012eb5c1795f63ef44bf0f03e6c91a8bc5bf93bdfa44288e02764c8dfcabb3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=41db2179d8691b0d49e9bc19245ac8af93d9c637a498ec7ab822269664452482;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=bb045204c5ffa7051c634c2e95e79c1cd747e7ef90f17f0028c79e8e43d17a9b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d0f07dbe50b17d281d72e7f09b962f4e75e676ff37d2497a1f6c721b17148d66;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=b9ea87e34b63b2829a4325cb9a3b6735aaf98ad39f4281a228b69dcdef430130;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=83e5f80b1c797b84fc0cb2cd64de1f93ba161fc7250d6638f1cfcdbfd8cbb1b6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=c38c7f036a705ba76a61d74c12e731be96998f55f2d811acaf0be815077ada0a;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=26d51bb9b7c9974b5e753fc3520ffcfa2abdbd132509a887f4a5bc5630aa05d9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=8debf2cb55d0f1b7011f183b83cc855caf6f06cbde5d34ff4449ac79b9f1abfb;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=335a0dc4a512dca9beb8390740b17ead2209d5e8550c970940668936df336e32;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=8793b789423fd13e39994b0f71a0659cdb8b79b8ab968e276050762d42f60c97;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ffec2a7d87781f847089728bd219d4ecd7dbb6701ac6688b994e754330172c20;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=e4831d0fe318c0dfe320eb9be0148336ad1a096e5a3f8675fe517ec2b5d82de6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=1abf4349b13234e9b9fe664e01960425da9b129ab4b0672a69a7103ff2bbf1b3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ab989ee5292af30a60ec0513ddc11cf15438035981075b0857e0d057d010c1fb;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=71311839d3cc0bad372e4d15ada1c2ecfbbac8c1909b23e11ad9689d1cd384eb;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=3d2fee3d76b8059823c9262d59d1842189785bf37241b8df5c12f8a261598e35;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=7c73cc5443237b3ac33d4578f03bfe1a94bb3ce14e7ec695ea6af93cbc6ba829;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=46289e477dc440bdafb440b79c282ebc60c7265daca677a5cba4863eeac20fa9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=03037cb67402cd2882ddc346bbbcacf2574475a18fef75aa96b2e42fc90532d9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ad911862aca0a6b42d094875b3135f5a8e850ce1a11394dca9913cda419fe972;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=02cc37502f6301e4feb5b9b80e2ddbb71dd875d54eb8cf012348502978492251;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=80f413de9f21648f16e847198f9ebc09c4df71a671657caed4d3e31caa55929d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=8c2c7b95015ec9f664ed6225a09edc37e7697c2dc911a12e6d19e1cbef6400e7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=04f3767cc1c78f1c22b06d659d308741a588e272ee723b39f744913ad669cd6e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=b79580c5b084a20cd9d522fa745b78bc86c0c0b1172e150112e05f1cc4c8304d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=0289a1f386ad8b0778979ad178afc509fd403a198c98b926a7d2866fb0f886fc;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=7a376ec159162bfb8cec3d947ced67d9b1394ebac3ce1220da6f1b80e6197edf;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=36b945ee0e5c10e51bc0eb32ec06b3b1745c5ad2814d376b5ceccfd96e5c5b3a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=90687ad9d09f7677ab6fc83f75b78bd3fed8a9934e071f071306007c79277dab;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=c38c7f036a705ba76a61d74c12e731be96998f55f2d811acaf0be815077ada0a;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=26d51bb9b7c9974b5e753fc3520ffcfa2abdbd132509a887f4a5bc5630aa05d9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=8debf2cb55d0f1b7011f183b83cc855caf6f06cbde5d34ff4449ac79b9f1abfb;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=335a0dc4a512dca9beb8390740b17ead2209d5e8550c970940668936df336e32;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=8793b789423fd13e39994b0f71a0659cdb8b79b8ab968e276050762d42f60c97;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ffec2a7d87781f847089728bd219d4ecd7dbb6701ac6688b994e754330172c20;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=e4831d0fe318c0dfe320eb9be0148336ad1a096e5a3f8675fe517ec2b5d82de6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=1abf4349b13234e9b9fe664e01960425da9b129ab4b0672a69a7103ff2bbf1b3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ab989ee5292af30a60ec0513ddc11cf15438035981075b0857e0d057d010c1fb;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=71311839d3cc0bad372e4d15ada1c2ecfbbac8c1909b23e11ad9689d1cd384eb;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=3d2fee3d76b8059823c9262d59d1842189785bf37241b8df5c12f8a261598e35;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=7c73cc5443237b3ac33d4578f03bfe1a94bb3ce14e7ec695ea6af93cbc6ba829;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=46289e477dc440bdafb440b79c282ebc60c7265daca677a5cba4863eeac20fa9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=03037cb67402cd2882ddc346bbbcacf2574475a18fef75aa96b2e42fc90532d9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ad911862aca0a6b42d094875b3135f5a8e850ce1a11394dca9913cda419fe972;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=02cc37502f6301e4feb5b9b80e2ddbb71dd875d54eb8cf012348502978492251;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=80f413de9f21648f16e847198f9ebc09c4df71a671657caed4d3e31caa55929d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=8c2c7b95015ec9f664ed6225a09edc37e7697c2dc911a12e6d19e1cbef6400e7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=04f3767cc1c78f1c22b06d659d308741a588e272ee723b39f744913ad669cd6e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=b79580c5b084a20cd9d522fa745b78bc86c0c0b1172e150112e05f1cc4c8304d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=0289a1f386ad8b0778979ad178afc509fd403a198c98b926a7d2866fb0f886fc;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=7a376ec159162bfb8cec3d947ced67d9b1394ebac3ce1220da6f1b80e6197edf;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=36b945ee0e5c10e51bc0eb32ec06b3b1745c5ad2814d376b5ceccfd96e5c5b3a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=90687ad9d09f7677ab6fc83f75b78bd3fed8a9934e071f071306007c79277dab;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=c6872050642efc50838c33494a3f26c7a912efcda4b2d355306aab91b8a77db4;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=27daa3627c6baf36dd6500b5ff613e3b2550b869167947f42e23ba596f66ade4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=85b73e9079e9cd6fd8efd465a1d7cb632075eebd61536049e6e3b9b3e2fd661a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=8eaf6e7cd7af4825a2dcaebc5dd3897ce05b6bc1e6b642e278059b92a8e3fe83;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=eeec562d1a98640af7005338aa004e389a65ee1d8e2c9bd9d08bd1e9a2095753;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=5b557890e45f2aabf992413035f27efd8083136ab3672325e68f00b2431b6c40;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f9d19a40c8e96a56205af0a2f2b7290a94f07f82c9635cac07dd71c063a5fa64;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=cb69d1fba616ddc3cedf635f4a60d4e5a10e7206e091253e753900a02eac908e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=b31dbb31ade8cd2712f4def82dfc69fe473e66bd114485878466cd88714675a1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=66b579b673213c95751692e1322c794f179ebbf90d76f06b512c2bf05e7e9069;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=97530512fe3d55c750b838909f4f23326e988d266936d7d49d86b309e3276bcc;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=c6872050642efc50838c33494a3f26c7a912efcda4b2d355306aab91b8a77db4;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=27daa3627c6baf36dd6500b5ff613e3b2550b869167947f42e23ba596f66ade4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=85b73e9079e9cd6fd8efd465a1d7cb632075eebd61536049e6e3b9b3e2fd661a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=8eaf6e7cd7af4825a2dcaebc5dd3897ce05b6bc1e6b642e278059b92a8e3fe83;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=eeec562d1a98640af7005338aa004e389a65ee1d8e2c9bd9d08bd1e9a2095753;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=5b557890e45f2aabf992413035f27efd8083136ab3672325e68f00b2431b6c40;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f9d19a40c8e96a56205af0a2f2b7290a94f07f82c9635cac07dd71c063a5fa64;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=cb69d1fba616ddc3cedf635f4a60d4e5a10e7206e091253e753900a02eac908e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=b31dbb31ade8cd2712f4def82dfc69fe473e66bd114485878466cd88714675a1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=3180f8e34845d13e27dddd90486dba083cd87a340d919f75d29859766f7faee4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=66b579b673213c95751692e1322c794f179ebbf90d76f06b512c2bf05e7e9069;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=97530512fe3d55c750b838909f4f23326e988d266936d7d49d86b309e3276bcc;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=c8520defc94e82f4984f47e47d452a9d06d0643704636037feb2782a757df487;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=c8520defc94e82f4984f47e47d452a9d06d0643704636037feb2782a757df487;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=93db044aad3eaa4f6ff82647058c9cabc43087aed8738caabb5656a82d45d865;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=b87e55cef8e89a6b9e01ccc33a5442d214d9b387fb5167242ee5870765f1e40b;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=e28ac921f54f5818462d387b9c61bba5f72d25451cbc98f5e1804f741c1f1fe7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=206327a320b967baf95361f43e814ab0e7403364077c84c04722fbe9ec7d59d5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ca5d2c19174791eda451f1994223b4c5b78a668e5b135230f5149eb7d65a97d3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=50da2d6b3ff31238fea9f4ebb147722fc306715eea709cd1107d229810ce4202;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=957f3903f6dbe8d48a1e8dba183e12d8675e4a6596741aa976e2cf27764a66ab;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=350f647ea7d662181d621fc85e3ff5aec0df7cef64c67862b47042524e14d482;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a5cf51cebbb267ad48366801701eb3a8ec788f9ecff83b6635df09eff4c4a13d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=89b5c96294b740fe8ab15637d580539194634e826abc6c2da47ee994bfc2d41f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=25e28ea260c8efc00de88a0e7da3faaea440f68bd539d0fd84e7ae65e33969e9;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=6e6ffd2fababfb900f63401a704f75dd8edd7e063f826d6da01789aa2df983d6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6e8fdfbc1b6673a9e7f0753ee13f672156f7333fac3083316c7f2d2994019053;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=96abdb3df8257963934d256627e830afd34b535b61f1caff482994f8f85dbece;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=bb12d9bb26703270e2fcfbff31177ae565874daf2528647fedd249b6c2935cf2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6bb03952b5468708a1d1544dab4e4d542a649c1429f2b8e38877c2bf1abac6d4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=3180f8e34845d13e27dddd90486dba083cd87a340d919f75d29859766f7faee4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=93db044aad3eaa4f6ff82647058c9cabc43087aed8738caabb5656a82d45d865;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=b87e55cef8e89a6b9e01ccc33a5442d214d9b387fb5167242ee5870765f1e40b;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=e28ac921f54f5818462d387b9c61bba5f72d25451cbc98f5e1804f741c1f1fe7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=206327a320b967baf95361f43e814ab0e7403364077c84c04722fbe9ec7d59d5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ca5d2c19174791eda451f1994223b4c5b78a668e5b135230f5149eb7d65a97d3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=50da2d6b3ff31238fea9f4ebb147722fc306715eea709cd1107d229810ce4202;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=957f3903f6dbe8d48a1e8dba183e12d8675e4a6596741aa976e2cf27764a66ab;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=350f647ea7d662181d621fc85e3ff5aec0df7cef64c67862b47042524e14d482;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a5cf51cebbb267ad48366801701eb3a8ec788f9ecff83b6635df09eff4c4a13d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=89b5c96294b740fe8ab15637d580539194634e826abc6c2da47ee994bfc2d41f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=25e28ea260c8efc00de88a0e7da3faaea440f68bd539d0fd84e7ae65e33969e9;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=6e6ffd2fababfb900f63401a704f75dd8edd7e063f826d6da01789aa2df983d6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6e8fdfbc1b6673a9e7f0753ee13f672156f7333fac3083316c7f2d2994019053;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=96abdb3df8257963934d256627e830afd34b535b61f1caff482994f8f85dbece;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=bb12d9bb26703270e2fcfbff31177ae565874daf2528647fedd249b6c2935cf2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6bb03952b5468708a1d1544dab4e4d542a649c1429f2b8e38877c2bf1abac6d4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=cda8761bee34e8f7563e187e3ef25f09026b7f16a1d27aa6e920db7f2b79bc1c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d9b28bce2ac1e8c6a6ea51c8363ea95bf522dea7876935acb451648cfe407994;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=7873d357d8c24ff28988da18280b1bfe16205f96d8cdcdc27166cd20b2158200;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=fb00842bd1734e60502617b2527f525df3570b71df2878f9419bf3436b6d77d2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=290d0ca5c183044dfb5f98e84bd2ca1cdc2aab53a21f90070e15694bd111fe16;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=e47a532bbb49cb08688ac3d50b5229d72adb20ab9182dffbe43f7330533d89d9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=8ec9d907cdf12c3184889dbeded8466994a0cf8ce6aa8dea3d74eb94eaa238cc;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=908457166335b6e82c7d81a026f23bddad632c6119a410f87c61d96e9819fd4b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=0df54561b9dfce1f7cc6d2858f039c4303727558615b8b64364b09c963da19f2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=1a7f4e2b2564e194582ecffac318dfbe9d86f05a14aac53a5f2e2cd58840ee08;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=e068bb52df93bc7010fe0a106a4c020c3ca1a4df702450e1f2cbeb32498d2477;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=70d958f9e0d68cc6d34a0e135b06640396e9bcde18b8c5102befb70fd7f07093;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6904b15afae6c2a0b1db92b5722ae54d1806030063ff51e3454e76193b2a5191;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=8e4d0a4d30896e13a46ec1a156fd004b325aebb89e2a4bdcfce0d17f24356900;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=fadb396bcd77015f5a1a0dbdc830b53d9d9439ea9455173079b65e5221242029;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=60a8253f1851d8a39758a74494add89110fd06dfbef509afedc07fe3b0bd9f15;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d20a89efc7cea30166cb218ed5c1648db76ed824426a7b58ba50cbbe39191475;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f3c6585c83099259a929a7fc221b5702558e1bfd3ee5c9584a216a59f950aaff;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=875bfbff4c31a068c9824c557541698eea34f069a333d8aec6d2e6645a73d2fd;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=91b806330d0e632a29aac57bb4c22564728a6732fc25d7393a6075cc86ec86d8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=e3120ebeac83fcb6900883a1fd140d8871ba9c4e503203fc2058648ef636df81;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=fff28d604ad38acee1c554c2c8ae8106f1b7325c057436bdb75b87bf12897fbd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=e6c11c6fb5881ea37c29f9a93b0fca175c770670e1571034d32b3ad098b761ab;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d91afc2f2ce5e663c474bccf20ea8abd1fdcf1a1d735d8422712b36ea154040e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=57a0663fa71fd2018b62bf8a5a5090b31ca2a7bb834cf056d34a9ec8a9afdff8;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=62d006ea1569dae280707516235efbb551613e782526764b4698ad19e66e1177;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=729ae39c61839b5c6bb6d8ec86b4e41bd4073cc8fac262bd32732144b1608045;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=3ff03763c8288dca4d2513ab1f9ce95572eef640989b55b7ed10a722484ac238;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=aa65a09b407bbeb0954d4632fd062dd8487c6fd8cdcfbc6ee25213fbe40f184c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=929bd4be9261b766fed4e9b6eb5dc4ba79d4f9b74e9b2c36f23398835215b95a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=398e77278e5c2862fb2e8aad0059dca67ecf21af5a47df0c59c4e658aa882302;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ff1ae33882f94afb4a45a6e93d6871f835891aecc93d52799058a07f25a0f449;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=c5470714db694a4a422ae88accca649e5a1c1101caedd86d2585edb7a1ab4d71;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ebb906810ec699e562cb9358a0c4915317c76ed19bdf166cb8b26aa61c8d8696;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=e1b2d7684cd7ed797f54d3996d6e5ddde59728fc88304ef2ca66b0b8593dd4ff;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=27766c2342c1b5fba9fda91d7f6a3fdcf78d6b96da879b820675899bfcbf146e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=0f4a8719dbb0caa2e8b638fe74d6c6dac6ca5ee91e4423e421a2f013170a0ca9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=0a85375cbfa23eb57f9647c13fd4a774922afd325ecca61ecb70f165f9e4a2e7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=94cf9c15bcb2bf012d1fba51c4a2fd6e8796e7f0b749d99c805e24b8773e37b7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d2736f3a3d17df5d3dd2fcb76ecd3043e35464dd05b5b86e3722d86578c68eef;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=7c965565bb8202941bbc7995e015807e3817397353b46aed7fafd568ec445009;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=cdbcf2fc8ac3cd58a70dadea86a7d583d51754be9a38177c868368d3b1481976;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=cda8761bee34e8f7563e187e3ef25f09026b7f16a1d27aa6e920db7f2b79bc1c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d9b28bce2ac1e8c6a6ea51c8363ea95bf522dea7876935acb451648cfe407994;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=7873d357d8c24ff28988da18280b1bfe16205f96d8cdcdc27166cd20b2158200;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=fb00842bd1734e60502617b2527f525df3570b71df2878f9419bf3436b6d77d2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=290d0ca5c183044dfb5f98e84bd2ca1cdc2aab53a21f90070e15694bd111fe16;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=078773cc36a9ab58ece5c92e50368462dea52ded70f1b0da8c66e65066a3ce53;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=e47a532bbb49cb08688ac3d50b5229d72adb20ab9182dffbe43f7330533d89d9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=8ec9d907cdf12c3184889dbeded8466994a0cf8ce6aa8dea3d74eb94eaa238cc;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=908457166335b6e82c7d81a026f23bddad632c6119a410f87c61d96e9819fd4b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=0df54561b9dfce1f7cc6d2858f039c4303727558615b8b64364b09c963da19f2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=1a7f4e2b2564e194582ecffac318dfbe9d86f05a14aac53a5f2e2cd58840ee08;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=e068bb52df93bc7010fe0a106a4c020c3ca1a4df702450e1f2cbeb32498d2477;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=70d958f9e0d68cc6d34a0e135b06640396e9bcde18b8c5102befb70fd7f07093;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6904b15afae6c2a0b1db92b5722ae54d1806030063ff51e3454e76193b2a5191;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=8e4d0a4d30896e13a46ec1a156fd004b325aebb89e2a4bdcfce0d17f24356900;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=fadb396bcd77015f5a1a0dbdc830b53d9d9439ea9455173079b65e5221242029;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=60a8253f1851d8a39758a74494add89110fd06dfbef509afedc07fe3b0bd9f15;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d20a89efc7cea30166cb218ed5c1648db76ed824426a7b58ba50cbbe39191475;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f3c6585c83099259a929a7fc221b5702558e1bfd3ee5c9584a216a59f950aaff;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=875bfbff4c31a068c9824c557541698eea34f069a333d8aec6d2e6645a73d2fd;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=91b806330d0e632a29aac57bb4c22564728a6732fc25d7393a6075cc86ec86d8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=e3120ebeac83fcb6900883a1fd140d8871ba9c4e503203fc2058648ef636df81;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=fff28d604ad38acee1c554c2c8ae8106f1b7325c057436bdb75b87bf12897fbd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=e6c11c6fb5881ea37c29f9a93b0fca175c770670e1571034d32b3ad098b761ab;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d91afc2f2ce5e663c474bccf20ea8abd1fdcf1a1d735d8422712b36ea154040e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=57a0663fa71fd2018b62bf8a5a5090b31ca2a7bb834cf056d34a9ec8a9afdff8;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=62d006ea1569dae280707516235efbb551613e782526764b4698ad19e66e1177;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=729ae39c61839b5c6bb6d8ec86b4e41bd4073cc8fac262bd32732144b1608045;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=3ff03763c8288dca4d2513ab1f9ce95572eef640989b55b7ed10a722484ac238;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=aa65a09b407bbeb0954d4632fd062dd8487c6fd8cdcfbc6ee25213fbe40f184c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=929bd4be9261b766fed4e9b6eb5dc4ba79d4f9b74e9b2c36f23398835215b95a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=398e77278e5c2862fb2e8aad0059dca67ecf21af5a47df0c59c4e658aa882302;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ff1ae33882f94afb4a45a6e93d6871f835891aecc93d52799058a07f25a0f449;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=c5470714db694a4a422ae88accca649e5a1c1101caedd86d2585edb7a1ab4d71;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ebb906810ec699e562cb9358a0c4915317c76ed19bdf166cb8b26aa61c8d8696;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=e1b2d7684cd7ed797f54d3996d6e5ddde59728fc88304ef2ca66b0b8593dd4ff;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=27766c2342c1b5fba9fda91d7f6a3fdcf78d6b96da879b820675899bfcbf146e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=0f4a8719dbb0caa2e8b638fe74d6c6dac6ca5ee91e4423e421a2f013170a0ca9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=0a85375cbfa23eb57f9647c13fd4a774922afd325ecca61ecb70f165f9e4a2e7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=94cf9c15bcb2bf012d1fba51c4a2fd6e8796e7f0b749d99c805e24b8773e37b7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d2736f3a3d17df5d3dd2fcb76ecd3043e35464dd05b5b86e3722d86578c68eef;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=7c965565bb8202941bbc7995e015807e3817397353b46aed7fafd568ec445009;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=cdbcf2fc8ac3cd58a70dadea86a7d583d51754be9a38177c868368d3b1481976;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=8f456a908208dcb5f4fb5167a1b7e977d2b644935aeec1af0a6d647af410d828;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6e3abcccf3140ce064846be83b92e0d93c9140e8e704125480bfa49f4c57fb57;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f837f50314409b71ad656412600a3a034ef97816e1717c200ccea489b29cbedc;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=856ab6587efdba886756df5a30511a26027e646b37aac2759c06f5209c241c88;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=39967f20672678ab9fbeb33d30920937ad5e1a4b0485382920ac1fee8edcadbe;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=02d3c7c002a875493e63877e5517b7432c95b2b522ba67384c873737b9bab3b7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ffedffc3ce438befa0e4d0c20dc30ac3575ad8df98f4acab601279ee7ab35f14;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=29a625999b8102746891f4265f9aa80f576db0b4c9456ec553ff482d3c40d130;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=0c18dae928d5146c8b0d052a9ceffa02ef1e1dcd70f6e5c321dc37c264d9c9d8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6e270bf02cdf88374d9793eb09c46eafc1e11e29020b29b526640302fbf544a2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=934fe84809fc20a81f124747d5ed57817eb0f9120ea63a69a1548d514710978f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=4e8a9e9de13e84cb13e7f68253d35f16e193470fcdb70f686c8bacfd2424356a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=cb5a5cc0336981375208f731fe0f52f391d51f6bc6742746b19ddfd58e6f83e4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6be55759a31337c704a5cf2aa0b9a8848ad9305bd73b7291b2e5dca768e9a649;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=16ecc4c79c9ca8e731e9b0f2c6084c63a222890ad8d448c3658736dbc6eff424;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=3709a5a3c78b4c21fbcb1c6a15585b054c7d38d78a1eaa3ee4e307b79c11a245;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=21c3e02f465c21c25f5d7f686b2a5c008b23a2fe5469d444ebac07f80a1ab962;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=2bad03c19cab85257edda097fbdaabccfe32f966ead99afe275023e0423afec1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=8f456a908208dcb5f4fb5167a1b7e977d2b644935aeec1af0a6d647af410d828;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6e3abcccf3140ce064846be83b92e0d93c9140e8e704125480bfa49f4c57fb57;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f837f50314409b71ad656412600a3a034ef97816e1717c200ccea489b29cbedc;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=856ab6587efdba886756df5a30511a26027e646b37aac2759c06f5209c241c88;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=39967f20672678ab9fbeb33d30920937ad5e1a4b0485382920ac1fee8edcadbe;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=02d3c7c002a875493e63877e5517b7432c95b2b522ba67384c873737b9bab3b7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ffedffc3ce438befa0e4d0c20dc30ac3575ad8df98f4acab601279ee7ab35f14;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=29a625999b8102746891f4265f9aa80f576db0b4c9456ec553ff482d3c40d130;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=0c18dae928d5146c8b0d052a9ceffa02ef1e1dcd70f6e5c321dc37c264d9c9d8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6e270bf02cdf88374d9793eb09c46eafc1e11e29020b29b526640302fbf544a2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=934fe84809fc20a81f124747d5ed57817eb0f9120ea63a69a1548d514710978f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=4e8a9e9de13e84cb13e7f68253d35f16e193470fcdb70f686c8bacfd2424356a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=cb5a5cc0336981375208f731fe0f52f391d51f6bc6742746b19ddfd58e6f83e4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6be55759a31337c704a5cf2aa0b9a8848ad9305bd73b7291b2e5dca768e9a649;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=16ecc4c79c9ca8e731e9b0f2c6084c63a222890ad8d448c3658736dbc6eff424;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=3709a5a3c78b4c21fbcb1c6a15585b054c7d38d78a1eaa3ee4e307b79c11a245;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=21c3e02f465c21c25f5d7f686b2a5c008b23a2fe5469d444ebac07f80a1ab962;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=2bad03c19cab85257edda097fbdaabccfe32f966ead99afe275023e0423afec1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=eb01c179c96883f021d76d3724e2fd64d580d2e11f2fbbbcab6b83d8e8ffbb3d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=eb01c179c96883f021d76d3724e2fd64d580d2e11f2fbbbcab6b83d8e8ffbb3d;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=e4b80679fbce7ca2acb63fd127363572dc0ca706328a1932fdee2358a9080110;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a575fa3a084b236bdcc6c02c119e643d4bdd9cb84bcac4716fca07bc2b74fcf1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a291ec924b460d7dacd1deae82a5e9247c3770de28cd2f202014f24edd27fdbc;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=e93d48436c2be6a3704bb914c29940a4198d5c8d9f25d25de3cbf48db41c8c1c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6ba738d1b7f1289ce2bf360743238837586ae068c0b87a6bda8f7731589f8238;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=da39706c902081bc4de43f099bf43e63bd8e796caf962e6614b138ce648015ac;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=75ce1bd6dbaf2d4ca50f51e6c1f2a09f3275b080539a07ac7ed962ae72c5179f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f4661599926f32245eb1f3e52788501bd0897f45a6b27ca5cdede18edb14be28;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=b8b2821ff551cc8cbf1e4a991c8b194f55891abaf407569629bcb3acb131c19a;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=cd056b00c8eea9e5c9bcae0bdf268f74dcd3ff4ab85c71752c76792e7937234b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d9ae1705ce0b4462ff82a46be3d5304819ffddc3715bbb6afd6e6181b8519846;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=be968792772699a12e22c87670fa3f80e7c142271bdd98b62f4fb62f8fd4595c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=c663059a37d1a1a67f9db09184aba83ae618af0e1717aaa1650eb81abaa83e10;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=5653075dfbef8dbf0fd2c89d49e162c3decfdf3b62db87ee57a7124937af2792;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=490ae7348c12a59b53192e341610b5c588783c80cbd969631ecf953ad0baf508;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=1395dc4ab7c754e0a84c8daa3996f16e5caf11169f8a9be6c800f6da00474321;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=c9db481edc32ce76746d2f099953d6010d3bd2d53c4ede5b89c5339ce551798c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f12cb40ba608e9ba3fd0d02ba87d2b42dc97e4a7c12debe83992b750aa93f2f2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=69f1b2078352cbdee29724b705114ad434578dbfadf5a8df2f82fdf3cde3f72b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=94649c5b2157e86623cef4ed305f17ab35a8026fde844bf59ba8763b5949c417;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=b1e3464f5718a6c674ee1a8da4a92ab7cc4f892e1b2e7a25cc7401f5c734124e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d79836f11b8c4e35b1d6ea1b73432c12faf524365b705494a0b69a6a96e81dca;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=37b56a8f3ae8e0f59bb17651a17a967c62f68204140b18b7d013c9eb709c69d2;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ea9ee2acb5fbb50f049bddc8297fe4cb8652b8990328281283bddb5b6cdb920c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=0de0307feaaebcd92622acc19aae9d7ee9ba2f58ebfbfa0f8523e7c4f1b6b3ed;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=8812182da457dd94138bb1bd66a4c1daeccb446a4c79d31b05d0c0bfb1ff3507;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=913ce613b66ab4f7fda444db13933c39c689bef153aaa1cbe05db00e4aa7a1a4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=b8bfd29057a30c787f3ce32ad6fd64aeb349043a52c25d917cb28644bc0a48a0;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=57b7a98ac74112257612b3cadd241ef30d2cf823cac485e03f450365b7c6c789;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=dc28fc658e49e8706e5bc935d936179bb301b40fa1c23c6b4a79e12a72ead1e3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=04feb20b0eef08db14ff7df6ef52bd0f71fbaebc9fbb6099da2dafedd1ddef9a;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=4f47f6288df7369b28f5c8b57440ea1196b2d92fca571abc1c83c18062924dc3;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=4f47f6288df7369b28f5c8b57440ea1196b2d92fca571abc1c83c18062924dc3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d24acdce61e6c3eacd25728dfceea573cb8ebbb4a0f81179e38b9d91783b064f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d24acdce61e6c3eacd25728dfceea573cb8ebbb4a0f81179e38b9d91783b064f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=c4576ef6950092fd647b7e0ccdf5e46cbfa3da5648f93f5e8c40f76bbf59fad3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=c4576ef6950092fd647b7e0ccdf5e46cbfa3da5648f93f5e8c40f76bbf59fad3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=05fb093d1b2af292cf0795316e9afefc4407f42256c914edeee9ac881e1d435c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=05fb093d1b2af292cf0795316e9afefc4407f42256c914edeee9ac881e1d435c;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=a3cb977c05d7d352217dc61aab127ad808f3ceeba73e0f29d66a6413e1dd9ca7;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=a3cb977c05d7d352217dc61aab127ad808f3ceeba73e0f29d66a6413e1dd9ca7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a3b92e88191e182682ecd6b5e9bd293f729df82ddae31832b68b6e431e92d5a9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a3b92e88191e182682ecd6b5e9bd293f729df82ddae31832b68b6e431e92d5a9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=0b64dd9e11bfd9b7413d9bc770587b6a011e6946109f1ded24bc92444941450f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=0b64dd9e11bfd9b7413d9bc770587b6a011e6946109f1ded24bc92444941450f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=77e647a05a7bc6591ccdaaab2bbdef656649418e52d8f02e6f7f5d63af2f50fb;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=77e647a05a7bc6591ccdaaab2bbdef656649418e52d8f02e6f7f5d63af2f50fb;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a753fb90260943b0a5a428599b41a14fa4afdfafd38a6284f0b02db1b5c204d6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a753fb90260943b0a5a428599b41a14fa4afdfafd38a6284f0b02db1b5c204d6;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=3abbfc149ac774b3bfed61438c5b709a473c0c6162b6707b4bfebef67eba2260;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=3abbfc149ac774b3bfed61438c5b709a473c0c6162b6707b4bfebef67eba2260;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=cd65d105ecaafbe94b32932c5444b28fa23317020bdd82012babdca9266577fd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=cd65d105ecaafbe94b32932c5444b28fa23317020bdd82012babdca9266577fd;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=b095be882857633de948faf0619072298aa64461fd058af02352f8961c273320;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=b095be882857633de948faf0619072298aa64461fd058af02352f8961c273320;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=fc9a6db4412fe7bd4e1b33debfdfe8a23bb42121d683d7cc06f48ba669595fe5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=fc9a6db4412fe7bd4e1b33debfdfe8a23bb42121d683d7cc06f48ba669595fe5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=0985a2e91070b77b0b7c61278b04d7c88864c3bc670f211bdb54bd09d271e986;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=0985a2e91070b77b0b7c61278b04d7c88864c3bc670f211bdb54bd09d271e986;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2567f5779f07b4c5c7eb5ef5590da72b4352f0e6353150b2f090c354721bebac;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=2567f5779f07b4c5c7eb5ef5590da72b4352f0e6353150b2f090c354721bebac;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d2588a7edd6efd35550bc49ebb03aae4445eec879c3a29a0c15e5a73654f2d04;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d2588a7edd6efd35550bc49ebb03aae4445eec879c3a29a0c15e5a73654f2d04;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=cd65d105ecaafbe94b32932c5444b28fa23317020bdd82012babdca9266577fd;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=b095be882857633de948faf0619072298aa64461fd058af02352f8961c273320;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=04feb20b0eef08db14ff7df6ef52bd0f71fbaebc9fbb6099da2dafedd1ddef9a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=fc9a6db4412fe7bd4e1b33debfdfe8a23bb42121d683d7cc06f48ba669595fe5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2567f5779f07b4c5c7eb5ef5590da72b4352f0e6353150b2f090c354721bebac;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d2588a7edd6efd35550bc49ebb03aae4445eec879c3a29a0c15e5a73654f2d04;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a753fb90260943b0a5a428599b41a14fa4afdfafd38a6284f0b02db1b5c204d6;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=3abbfc149ac774b3bfed61438c5b709a473c0c6162b6707b4bfebef67eba2260;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a624a0c1c1913bae5bbae8811ee75a6c5150308de7321ab7ac13247677335bfa;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a504c27a1fd7af3a53e0b5108cc052cab5ff8d1a353800e85ea8eec766707bde;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f8b3f47b00dacdd3247c0452ab29c6b05822bc0cdc369d59f0747bb609554338;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=70f91704e9653694e7ac63af2d817e56414f4fab3c54994f6744a7cc28bbe645;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6c53d8df4b1cabae706250c0eb7a58908a8f12cebf7812218513c0c4633e13c6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a624a0c1c1913bae5bbae8811ee75a6c5150308de7321ab7ac13247677335bfa;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=04feb20b0eef08db14ff7df6ef52bd0f71fbaebc9fbb6099da2dafedd1ddef9a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a504c27a1fd7af3a53e0b5108cc052cab5ff8d1a353800e85ea8eec766707bde;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f8b3f47b00dacdd3247c0452ab29c6b05822bc0cdc369d59f0747bb609554338;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=70f91704e9653694e7ac63af2d817e56414f4fab3c54994f6744a7cc28bbe645;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6c53d8df4b1cabae706250c0eb7a58908a8f12cebf7812218513c0c4633e13c6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=5e49d3e75f5a5faefb000800dda151a99cb2efe29603c7437a4a234c88bbb383;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f0e5bb894c49e0e03825e7341f587c1848aa203384f70cd0edaf7f76c3af2c8b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=7e5fe54682f97841fdf2cea1ac5a3a9b0944e8de6a5bab414be5953e4a122203;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=314b3b4419dd1967f0dc9d10e75e3c7e9fc44d9ca43a0994f5c53cb4bee343b3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=e2aeac309d13554e37f1444afa40b383005f7edb99e40588c1e8fab9931dc81d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=e690adbb9f70f16aad05be4aedda090d0c444522844f6f8d51df380106e4ce49;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a25ba6991cdc90fb66cef9fa154d52f67ffce6d271a18c9fa33cb82ebac6d964;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=5b04c05bf5123ac16736f99285b1e7836815beab7399a4ffe44dc5c70e71a5e1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=eb2129a387569f511d7a26d2426d057673d2cdf75a5d847f8f1cf116f1816b01;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=513a077abb45b77174564db736c795e80db50fb6613c65dd52ac30362f5ac7a5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f3ff3bc6be71efe394d7d3bc6e06b6461937a7d825272189d03703e3691b4f30;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=9dbb90a23f2804ff80e9633a1d4e16caa73f62200ad5de955ff35782a0d756bd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=fb7630da01d0cd9d9e94a5b5202a0f97873a7ae9302ae8b33aadd3274f6c291b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=48bba806613d4dc7b432d75c0069ee314684f6d69e3f52503b52f3150448dc14;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=1aa5c1b7dc0951139f6eee1476ac8edcba8ddee881eeec50897c81d13d42a4f6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=da859c8e95cc5acefde4e70aaed8fc89449c2aa5d9a6cef6202041987840e0a3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=1b2666062ba4458789d5500896b198fc548feea869a79eabd35e141fdab59c09;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=e371d3d80a557bcca0c432e286e31b320554ca59adccb179f38e5c3bbb2a0a0e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d36f854150d37a7ff0382047dcbe684c3c6247e07dd28de26c34f4e046ac2db5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=5dc4cf7cf944d91a6b9f54b6cd4aacff655f469bfa2e2569187f4ca7b20d1f5f;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=23b4e52e36a71bfaec31dc2edd3dd8e6e470acab656279f96446223d654bcc2c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a46434e58a34e0e99f630629c94f09d33e002444d02c39269165de26d985718d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=660c9e00a1f27e8139f554e6b56a85eb55647e1ad41d7ecac296dd62a039a71e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=81ed35f07e98127b64788fc315b51a78276fc69247cc9181dbf94096659eac2d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ede9d5169929a219ad3172388cff1c027c414717341449633414330b85746bd4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=69445a60bb3d928af26692ed3220960c8f142c5863af068392e92837bf271819;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=b83276e275db581581238ffb61e2680ef11a9bb54ad19bc8f70fbee175d10b5d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=158cfbabcfd84336aa6020a4d6ada78d4cc56ae83802bc9e556d5d8db44af5a0;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6045efd1568af8638ab9b45cd3982c9f44b2d856d87e197792319997cdc4ab92;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=92e63aeec5d5bfb17bdf90ebb4da303a859f9d663ef931cdd8fc89ec4d807919;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=eceb44da19ee3715c17ffb12e56c8ce4a25061e052f0da1267bb36ba0a4e2f23;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ce9a526645ba13e896ad4b1064491b79b8a5d091768299fbe2eae74f4c5b7c24;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=fb1c71971284e6a79676c65bb385dbe329a43c2ac9aa36e5add6f7c1eba0db49;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=dbdc97310a0875cbdc300e28039a070298a95866ea6b6e3d25d80fa48bc44579;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=c3665bc6f6a1cdf8269db11e730221a95e50887912aaa0111c80ad13afa58eed;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d40d194d9493bd72f8125a6aa6e6cdeca41845e8ab0fc204301d01c3f9559bbd;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=a8abb113e589e360a9aaa31db4883f56206e49bc70b6d3577eb4736ba40018d7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=9dbb90a23f2804ff80e9633a1d4e16caa73f62200ad5de955ff35782a0d756bd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=fb7630da01d0cd9d9e94a5b5202a0f97873a7ae9302ae8b33aadd3274f6c291b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=48bba806613d4dc7b432d75c0069ee314684f6d69e3f52503b52f3150448dc14;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=1aa5c1b7dc0951139f6eee1476ac8edcba8ddee881eeec50897c81d13d42a4f6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=5dc4cf7cf944d91a6b9f54b6cd4aacff655f469bfa2e2569187f4ca7b20d1f5f;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=23b4e52e36a71bfaec31dc2edd3dd8e6e470acab656279f96446223d654bcc2c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ede9d5169929a219ad3172388cff1c027c414717341449633414330b85746bd4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=69445a60bb3d928af26692ed3220960c8f142c5863af068392e92837bf271819;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=b83276e275db581581238ffb61e2680ef11a9bb54ad19bc8f70fbee175d10b5d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=158cfbabcfd84336aa6020a4d6ada78d4cc56ae83802bc9e556d5d8db44af5a0;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=92e63aeec5d5bfb17bdf90ebb4da303a859f9d663ef931cdd8fc89ec4d807919;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=eceb44da19ee3715c17ffb12e56c8ce4a25061e052f0da1267bb36ba0a4e2f23;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=c3665bc6f6a1cdf8269db11e730221a95e50887912aaa0111c80ad13afa58eed;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d40d194d9493bd72f8125a6aa6e6cdeca41845e8ab0fc204301d01c3f9559bbd;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=a8abb113e589e360a9aaa31db4883f56206e49bc70b6d3577eb4736ba40018d7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=da859c8e95cc5acefde4e70aaed8fc89449c2aa5d9a6cef6202041987840e0a3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=1b2666062ba4458789d5500896b198fc548feea869a79eabd35e141fdab59c09;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=e371d3d80a557bcca0c432e286e31b320554ca59adccb179f38e5c3bbb2a0a0e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d36f854150d37a7ff0382047dcbe684c3c6247e07dd28de26c34f4e046ac2db5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a46434e58a34e0e99f630629c94f09d33e002444d02c39269165de26d985718d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=660c9e00a1f27e8139f554e6b56a85eb55647e1ad41d7ecac296dd62a039a71e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=81ed35f07e98127b64788fc315b51a78276fc69247cc9181dbf94096659eac2d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6045efd1568af8638ab9b45cd3982c9f44b2d856d87e197792319997cdc4ab92;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ce9a526645ba13e896ad4b1064491b79b8a5d091768299fbe2eae74f4c5b7c24;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=fb1c71971284e6a79676c65bb385dbe329a43c2ac9aa36e5add6f7c1eba0db49;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=dbdc97310a0875cbdc300e28039a070298a95866ea6b6e3d25d80fa48bc44579;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=b9c930ab63b7407c3fa8c53f8552e1a66ab9f970dfc436e2e51bd05414618648;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=97a8da910044868e4b93f3bc66de54f863428a22b72f8e8c8896d562f7c970c3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6dbb23b5b9afd951a8e791a46fc4abe3e21b920313c9a90b650fac524a2075d3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=0c596e131276a9448805de75baf6d331353edc214a9edfb7c6f41908d6d3130f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=34f4a1f2b8d24914cefc12aee36ebb37504d07511b70fec088a1d4102da92df0;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=1527bc8b5a2bf76464676730388a7c05f30a7290fe2210e562cf5e0c7cac3345;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=0a60808f0d6e3b778273f426eeaa59435f9142b824da06a11ffc421128afb5dd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=7f7a57bd92a6a9ec9594699e0185f312b87450c4becb3627adcaab4bbd64c96d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=97a8da910044868e4b93f3bc66de54f863428a22b72f8e8c8896d562f7c970c3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=b9c930ab63b7407c3fa8c53f8552e1a66ab9f970dfc436e2e51bd05414618648;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6dbb23b5b9afd951a8e791a46fc4abe3e21b920313c9a90b650fac524a2075d3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=0c596e131276a9448805de75baf6d331353edc214a9edfb7c6f41908d6d3130f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=34f4a1f2b8d24914cefc12aee36ebb37504d07511b70fec088a1d4102da92df0;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=1527bc8b5a2bf76464676730388a7c05f30a7290fe2210e562cf5e0c7cac3345;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=0a60808f0d6e3b778273f426eeaa59435f9142b824da06a11ffc421128afb5dd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=7f7a57bd92a6a9ec9594699e0185f312b87450c4becb3627adcaab4bbd64c96d;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=717c0ec0d622284b444dd3421c98c8334805326532582873d1e4e23518de33b0;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=392af0c06be23bfc8f60361072a92268662bbd2b0d739201b5c2fbd34a15ff25;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=30e5afb25005a5e6be0c0de29595b2f386308b854a73ffb15317c461718205a3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=8cf58ec6aefc914022d30014ad2091b33ec3a4ee841d22ed964ec8d7ff515e61;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=d1d692f974e6dbbf5cc7610bed5e488d3d142979c7f3b01e199b273d70bd7fb8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=99febb5cb49a8d0e47fc43cb46c3c972af7077adde2b38b1919c294276ef563e;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=a968458c4aa5fb6e51d777b44f5fd8f0c563732d2c2a7ec5dc93cd5f8695407a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=cb938cf52fa2b27bdf2d234f30a67f7e766ec1731bae4fe380170a6ce5dd61fa;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=e26373e3064c37d6a8bc3cd736998e37a396e3f84e46ee0fb03d1d5d99a76c53;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=445fe324ced35562aa4eb787ace04dc826bbc25ec67b236bba7f226837270672;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=736816540afbfc3e46000e6c943e77f13e5f3c8e590750374d0b01e94448df78;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=43776438d2da3665682507747485430a7b1fd322b84446bcbf6a3e3dd9cfea32;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=18ca78d4585c3495bfe0961dc1c51ad36aea437da2e01f57756ced0514056b73;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=86068b946235d00d8fdea48c678acec11b3b7a094f6b5133a14ae2faaee2c8af;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=66a2d0738fe38f5b696b89088016921a5ba68467844906a415ad9c13c23f3f82;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d06edce9bcfc01daaf65ac43244b76ff54a7a6b548ae7dc38c4bfcc0c04dcdcd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=0963f143cc945f2bf680c16240ac6b8d44b6c39c65453f32bc773408db826c31;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=2638c364b22eb5c857d7ef4e6722b23232b2690383c5f34836cb2e9055e2a2fb;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=62731af34abfd9a368a3daca43f2ca2fdce78d50d02192ff8b7b68c9b179c591;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=3132e2e81d7312f93261cf771e6cc7fdb8e4800ad8d8f4049bc7ec800b08789c;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=717c0ec0d622284b444dd3421c98c8334805326532582873d1e4e23518de33b0;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=d1d692f974e6dbbf5cc7610bed5e488d3d142979c7f3b01e199b273d70bd7fb8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=99febb5cb49a8d0e47fc43cb46c3c972af7077adde2b38b1919c294276ef563e;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=a968458c4aa5fb6e51d777b44f5fd8f0c563732d2c2a7ec5dc93cd5f8695407a;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=86068b946235d00d8fdea48c678acec11b3b7a094f6b5133a14ae2faaee2c8af;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=66a2d0738fe38f5b696b89088016921a5ba68467844906a415ad9c13c23f3f82;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=0963f143cc945f2bf680c16240ac6b8d44b6c39c65453f32bc773408db826c31;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2638c364b22eb5c857d7ef4e6722b23232b2690383c5f34836cb2e9055e2a2fb;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=62731af34abfd9a368a3daca43f2ca2fdce78d50d02192ff8b7b68c9b179c591;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=3132e2e81d7312f93261cf771e6cc7fdb8e4800ad8d8f4049bc7ec800b08789c;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=392af0c06be23bfc8f60361072a92268662bbd2b0d739201b5c2fbd34a15ff25;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=30e5afb25005a5e6be0c0de29595b2f386308b854a73ffb15317c461718205a3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=8cf58ec6aefc914022d30014ad2091b33ec3a4ee841d22ed964ec8d7ff515e61;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=cb938cf52fa2b27bdf2d234f30a67f7e766ec1731bae4fe380170a6ce5dd61fa;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=e26373e3064c37d6a8bc3cd736998e37a396e3f84e46ee0fb03d1d5d99a76c53;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=445fe324ced35562aa4eb787ace04dc826bbc25ec67b236bba7f226837270672;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=736816540afbfc3e46000e6c943e77f13e5f3c8e590750374d0b01e94448df78;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=43776438d2da3665682507747485430a7b1fd322b84446bcbf6a3e3dd9cfea32;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=18ca78d4585c3495bfe0961dc1c51ad36aea437da2e01f57756ced0514056b73;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d06edce9bcfc01daaf65ac43244b76ff54a7a6b548ae7dc38c4bfcc0c04dcdcd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6375459929f5a6320351e3b8851211460359ccde0ca0d7e858aae8fdbdf77d73;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f766c67a2f3bc4d0cbb92614275ac052201cee5880928b2acd169e5802027797;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=70224ed441451a81fd89f696be5993bde735a85317aeeece976d443a155bb554;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6375459929f5a6320351e3b8851211460359ccde0ca0d7e858aae8fdbdf77d73;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6375459929f5a6320351e3b8851211460359ccde0ca0d7e858aae8fdbdf77d73;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f766c67a2f3bc4d0cbb92614275ac052201cee5880928b2acd169e5802027797;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f766c67a2f3bc4d0cbb92614275ac052201cee5880928b2acd169e5802027797;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f766c67a2f3bc4d0cbb92614275ac052201cee5880928b2acd169e5802027797;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=70224ed441451a81fd89f696be5993bde735a85317aeeece976d443a155bb554;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=70224ed441451a81fd89f696be5993bde735a85317aeeece976d443a155bb554;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=2982202423e350625a9213329f841b023190e587635c72c66de7a841b3e00b8f;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=5a6c12d7e4141588ba41e5a07c2fdf878a57510ea4957fddbe1ce88e51d57864;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a293752317dee4bd4904cb5d2a081581e8472f6445709fb2c0f45ee85217990d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=5e49d3e75f5a5faefb000800dda151a99cb2efe29603c7437a4a234c88bbb383;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f0e5bb894c49e0e03825e7341f587c1848aa203384f70cd0edaf7f76c3af2c8b;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a6d223164cca3826d327c57ac731da9f25584747d5f07781052aff2443d4ab2e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=39402fc51383058bbd48d13bfe8dc613c344e0cdf764561fa33f861bd0e362e8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=7e5fe54682f97841fdf2cea1ac5a3a9b0944e8de6a5bab414be5953e4a122203;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=314b3b4419dd1967f0dc9d10e75e3c7e9fc44d9ca43a0994f5c53cb4bee343b3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=e2aeac309d13554e37f1444afa40b383005f7edb99e40588c1e8fab9931dc81d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=e690adbb9f70f16aad05be4aedda090d0c444522844f6f8d51df380106e4ce49;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a25ba6991cdc90fb66cef9fa154d52f67ffce6d271a18c9fa33cb82ebac6d964;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=5b04c05bf5123ac16736f99285b1e7836815beab7399a4ffe44dc5c70e71a5e1;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=b0d1263eaf6c8f36ab1f54a617bbc331c85ff04bf58ad52e2a76eab31cf9dea3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=dad6778649d2378d03f4b02bb462e1483819a93872c24348bcdbb62b2c6fa047;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=eb2129a387569f511d7a26d2426d057673d2cdf75a5d847f8f1cf116f1816b01;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=513a077abb45b77174564db736c795e80db50fb6613c65dd52ac30362f5ac7a5;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=251e8f9e35d4eba93dcd32dea1f713609f4cf97b8e537637921a670c52dc9861;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f3ff3bc6be71efe394d7d3bc6e06b6461937a7d825272189d03703e3691b4f30;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2982202423e350625a9213329f841b023190e587635c72c66de7a841b3e00b8f;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=5a6c12d7e4141588ba41e5a07c2fdf878a57510ea4957fddbe1ce88e51d57864;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a293752317dee4bd4904cb5d2a081581e8472f6445709fb2c0f45ee85217990d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a6d223164cca3826d327c57ac731da9f25584747d5f07781052aff2443d4ab2e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=39402fc51383058bbd48d13bfe8dc613c344e0cdf764561fa33f861bd0e362e8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=b0d1263eaf6c8f36ab1f54a617bbc331c85ff04bf58ad52e2a76eab31cf9dea3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=dad6778649d2378d03f4b02bb462e1483819a93872c24348bcdbb62b2c6fa047;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=251e8f9e35d4eba93dcd32dea1f713609f4cf97b8e537637921a670c52dc9861;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f9b321ca7e0e9d738cc4bdc16df6335c03a699de6cfdc1f0aaec1d18f17654ad;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f9b321ca7e0e9d738cc4bdc16df6335c03a699de6cfdc1f0aaec1d18f17654ad;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f9b321ca7e0e9d738cc4bdc16df6335c03a699de6cfdc1f0aaec1d18f17654ad;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=0c78eb71d79db50fbce1e174c7f14f47c7422346bc9f161ae36160f5c06d2fbd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2e9faf28897dce9dfd86c06101eeb7398f945036f13b5f9d78dd02e113ca9ba0;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f9b321ca7e0e9d738cc4bdc16df6335c03a699de6cfdc1f0aaec1d18f17654ad;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=0c78eb71d79db50fbce1e174c7f14f47c7422346bc9f161ae36160f5c06d2fbd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=2e9faf28897dce9dfd86c06101eeb7398f945036f13b5f9d78dd02e113ca9ba0;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=2ebb7adee8dfe2f8b4c0820e9138453f3cf04251686f23b187dc30bbb52c7e96;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=86239462345aedb32f027ac695197cbe243d6984b0aa6e6f21f6ca8636a5f617;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=870e93691ab4f1c57e0b454595d646bf6a96e193e171625236d3704fbf8e3a0f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f741eb7454e6474919d5e75bcbdaddc5978b1993ed5d22dbd07e8b0e36e2d2d3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=1eb70f19ab2ed90ef04ee3f82ce470bae65c3538ea3722c564674916e7c99512;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=cbb3fe1356e892fcf4ab170f32437b31912d670782c764965203603bc9205337;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=250e75e0ccb2d6cc7b159cc37fab47a4b056ed820a46b82b00bf46b8e7c61c36;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=a672f9244a6fe9ee7e992f3b412d19aa481bd6b67586846bff56e20e5e2396b3;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=8e7b04ed4920cdfa2db0bff01a897ceed172392ec5ea964a2b1fa68d99117a4d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=7d8254a43db12e6da4fcb2218bbdd0f84ca3938dfc723c2442069f7e17e24504;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=11524e868cfd06698eab18840572b21e31ccc772b0a6d8695b31b16d44f17de9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=d4c95d7413e88f9739a2fb25dfdddb938f57520c6d76a454a6c3d037ea9ff977;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=92cefde85804d46c8fc92a226bc04bc70482c225e4bad8c3a491c83e7a9844a9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=29c92c826c9be32c9026e917449cfd9871bc5b0acf21bbd8981c43a46fde33da;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=3fff03c9f87217265b27301425821d28012ec9572f60666565d1d3dc802d1030;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=985acc6a7800cdb92bf96e459604d908526a5ca2af59d9f663979cbe2bcda0e7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=3ecd9b003fa28a4fde294f8a7b8f0f260fcf21f80d9ca1cf4e6312caab88c6a7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=fe0b3ead4cbb6ad5487dc879401aa46f1069031f2a308a20cc1b47086d932956;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f44e0972cfd2a4662deefb110296d0af72b94a8d35c4345d7a35b48341ece7c4;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=barrett's;subject_id=9a498e8b17034fd8bb534f0e65e12c83a73aa65908fd41f4a13f86cf35b3e0cd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ec3960b75b04a71a3556d04f59871aa6b5a6dd32c0738b859825533ede013b7e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=f751ad9c51d4d4b972e9bc370eeccbc3bfd4b5973511f08a36b8410baccf7cb8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=b26feac50fdbedc8eafcc6a61ae136ce3d2c1ec0a371f095e192f21588ebfa3d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=3fff03c9f87217265b27301425821d28012ec9572f60666565d1d3dc802d1030;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=2ebb7adee8dfe2f8b4c0820e9138453f3cf04251686f23b187dc30bbb52c7e96;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=86239462345aedb32f027ac695197cbe243d6984b0aa6e6f21f6ca8636a5f617;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=985acc6a7800cdb92bf96e459604d908526a5ca2af59d9f663979cbe2bcda0e7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=870e93691ab4f1c57e0b454595d646bf6a96e193e171625236d3704fbf8e3a0f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f741eb7454e6474919d5e75bcbdaddc5978b1993ed5d22dbd07e8b0e36e2d2d3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=1eb70f19ab2ed90ef04ee3f82ce470bae65c3538ea3722c564674916e7c99512;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=3ecd9b003fa28a4fde294f8a7b8f0f260fcf21f80d9ca1cf4e6312caab88c6a7;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=cbb3fe1356e892fcf4ab170f32437b31912d670782c764965203603bc9205337;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=fe0b3ead4cbb6ad5487dc879401aa46f1069031f2a308a20cc1b47086d932956;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=250e75e0ccb2d6cc7b159cc37fab47a4b056ed820a46b82b00bf46b8e7c61c36;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f44e0972cfd2a4662deefb110296d0af72b94a8d35c4345d7a35b48341ece7c4;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=a672f9244a6fe9ee7e992f3b412d19aa481bd6b67586846bff56e20e5e2396b3;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=8e7b04ed4920cdfa2db0bff01a897ceed172392ec5ea964a2b1fa68d99117a4d;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=9a498e8b17034fd8bb534f0e65e12c83a73aa65908fd41f4a13f86cf35b3e0cd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=ec3960b75b04a71a3556d04f59871aa6b5a6dd32c0738b859825533ede013b7e;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=f751ad9c51d4d4b972e9bc370eeccbc3bfd4b5973511f08a36b8410baccf7cb8;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=b26feac50fdbedc8eafcc6a61ae136ce3d2c1ec0a371f095e192f21588ebfa3d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=7d8254a43db12e6da4fcb2218bbdd0f84ca3938dfc723c2442069f7e17e24504;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=11524e868cfd06698eab18840572b21e31ccc772b0a6d8695b31b16d44f17de9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=d4c95d7413e88f9739a2fb25dfdddb938f57520c6d76a454a6c3d037ea9ff977;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=92cefde85804d46c8fc92a226bc04bc70482c225e4bad8c3a491c83e7a9844a9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=29c92c826c9be32c9026e917449cfd9871bc5b0acf21bbd8981c43a46fde33da;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=e5bce2d839dc7736f8efebae58cb2a5f50ff261db785b8831e4c438bfcc5b936;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=932be781385ee8928b7497f31bc76e2d39794e65797f0afed7f025f46f63de04;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=89cc2856c17f27873ac56923ca22bc8282e5fbc5180670cd8917db51ffcc588d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=6da40d823948f5dc6ccd01b4c9703cd86cdbfc7448384c185f067789a018a5be;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=da18c31db546064e13e52c2588336eeb857884ce6c49971652647270c1791c08;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=fa37be85256c1efbac0501eb13ae1daf9f0fcaff4a7cbb3d2f4420f70f75d334;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=fbfc6db2b112a17deba998fee516899a4e6acf64b784dd7289cb18f7cfe5d1c3;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=493bf7322b8c18365466c43bf7a9e119bd4d7782147f9bc368bf4909539c43de;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=fea8e6717ae789b7a0d25764f7f96d653d0d4aab39892c2c6323aafdda63b4ba;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=c72589bc8e2b3e3e7373fbf0b5adb4c67dfb65afa28950d68bc08e94b4e5f6e6;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=674447974a213869433fdecef1d7825dcfbd972fa94ee78e89300dcd4e90fda9;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=42a2b2ad86b3d0f66ecec5ce1d8b0cca6e334d365d6434d2bf1050e9b2f97990;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=ffe2e6c271347f25927c6e8975685a1b04934a0406f589f3df1608de00a7719f;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=7848bd725874b4f28f5c907834fab039f1c9489938a6d78b770e367be2973da9;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=3f09772b941e0dc3721126176238df54197fca741e9c633c0860bc68791c6e7a;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=04616fe602821be83f79e051c94c28347907f72d4e9ed5d7f1f50d4cfcd71d01;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=e5bce2d839dc7736f8efebae58cb2a5f50ff261db785b8831e4c438bfcc5b936;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=932be781385ee8928b7497f31bc76e2d39794e65797f0afed7f025f46f63de04;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=abe0a2a743467f12a0a73ea6ef97fb1e22252f323b8400b41fa90d4526b58d12;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=89cc2856c17f27873ac56923ca22bc8282e5fbc5180670cd8917db51ffcc588d;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=98011f8fb58fa8eed6171691d09d2ac7c67eb943046e45f70c47352c3a559887;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=c7bfd214f91659c29c94ced600fe7a2ec9409351d81f69446f129280522b09dd;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=6da40d823948f5dc6ccd01b4c9703cd86cdbfc7448384c185f067789a018a5be;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=da18c31db546064e13e52c2588336eeb857884ce6c49971652647270c1791c08;ENA-CHECKLIST=ERC000026;
